Please provide your email address to receive an email when new articles are posted on . Chart review yielded 38 persons with MS and cancer treated with immune checkpoint inhibitors. Thirteen patients ...

A study of more than 22,000 people with multiple sclerosis (MS) has for the first time identified a genetic variant associated with faster progression of the disease, an accumulation of disability ...

Two complementary predictors (DAAE-M and ELIE) estimate individualized 5-year progression risk using routine clinical data, ...

Serum concentration of neurofilament light (NfL) may predict disease progression in patients with multiple sclerosis, new research suggests. In an analysis of an international cohort, risk for disease ...

In contrast to traditional measures, such as an increase or worsening of lesions or overall brain atrophy, to signal progression of multiple sclerosis (MS), investigators are proposing atrophied ...

Disability progression independent of relapse activity (PIRA) -- sometimes referred to as silent progression -- is a key integrating concept in the contemporary view of multiple sclerosis (MS). "The ...

People with multiple sclerosis (MS) may have symptoms that relapse, steadily progress over time, or progress from the onset of symptoms. MS is a disease of the central nervous system (CNS), which ...

Multiple sclerosis (MS) is a progressive disease of the central nervous system that can cause symptoms throughout the body, including both physical and cognitive symptoms. Obesity in childhood and ...

Making certain lifestyle changes alongside prescribed therapies may help alleviate MS symptoms and slow the progression of the condition. Including moderate exercise in your routine may improve ...

In relapse-remitting multiple sclerosis (MS), people experience periods of high MS activity where they have more symptoms or imaging tests show inflammation. Between these periods, the condition might ...